Molecular basis of branched peptides resistance to enzyme proteolysis

Chemical Biology and Drug Design

Volumn 69, Issue 3, 2007, Pages 216-221

  Falciani, Chiara ^a   Lozzi, Luisa ^a   Pini, Alessandro ^a   Corti, Federico ^a   Fabbrini, Monica ^a   Bernini, Andrea ^a   Lelli, Barbara ^a   Niccolai, Neri ^a   Bracci, Luisa ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Dendrimeric peptides; Half life; Protease; Stability

Indexed keywords

LEUCINE ENKEPHALIN; METALLOPROTEINASE; NEUROTENSIN; NEUROTENSIN[8-13]; PEPTIDE;

ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTHESIS; MASS SPECTROMETRY; MOLECULAR DYNAMICS; PLASMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SERUM;

AMINO ACID SEQUENCE; ENDOPEPTIDASES; ENKEPHALIN, LEUCINE; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEUROTENSIN; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

TETRA;

EID: 34247270115     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2007.00487.x     Document Type: Article

References (17)

1. Mammen M., Choi S.-K., Whitesides G.M. (1998) Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed;37:2755-2794.
2. Bracci L., Lozzi L., Pini A., Lelli B., Falciani C., Niccolai N., Bernini A., Spreafico A., Soldani P., Neri P. (2002) A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin. Biochemistry;41:10194-10199.
3. Lozzi L., Lelli B., Runci Y., Scali S., Bernini A., Falciani C., Pini A., Niccolai N., Neri P., Bracci L. (2003) Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency. Chem Biol;10:411-417.
4. Bracci L., Falciani C., Lelli B., Lozzi L., Runci Y., Pini A., De Montis M.G., Tagliamonte A., Neri P. (2003) Synthetic peptides in the form of dendrimers become resistant to protease activity. J Biol Chem;278:46590-46595.
5. Pini A., Runci Y., Falciani C., Lelli B., Brunetti J., Pileri S., Fabbrini M., Lozzi L., Ricci C., Bernini A., Tonello F., Dal Molin F., Neri P., Niccolai N., Bracci L. (2006) Stable peptide inhibitors prevent binding of lethal and edema factors to protective antigen and neutralize anthrax toxin in vivo. Biochem J;395:157-163.
6. Roques B.P. (2000) Novel approaches to targeting neuropeptide systems. Trends Pharmacol Sci;21:475-483.
7. Brown C.K., Madauss K., Lian W., Beck M.R., Tolbert W.D., Rodgers D.W. (2001) Structure of neurolysin reveals a deep channel that limits substrate access. Proc Natl Acad Sci USA;98:3127-3132.
8. Natesh R., Schwager S.L., Sturrock E.D., Acharya K.R. (2003) Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature;421:551-554.
9. Hughes J., Smith T.W., Kosterlitz H.W., Fothergill L.A., Morgan B.A., Morris H.R. (1975) Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature; 258:577-580.
10. Carraway R., Leeman S.E. (1973) The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem;248:6854-6861.
11. Garcia-Garayoa E., Allemann-Tannahill L., Blauenstein P., Willmann M., Carrel-Remy N., Tourwe D., Iterbeke K., Conrath P., Schubiger P.A. (2001) In vitro and in vivo evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors. Nucl Med Biol;28:75-84.
12. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., Bourne P.E. (2000) The Protein Data Bank. Nucleic Acids Res;28:235-242.
13. Binkowski T.A., Naghibzadeh S., Liang J. (2003) CASTp: computed atlas of surface topography of proteins. Nucleic Acids Res;31:3352-3355.
14. Koradi R., Billeter M., Wuthrich K. (1996) MOLMOL: a program for display and analysis of macromolecular structure. J Mol Graph;14:51-55.
15. Pastor M.T., Esteras-Chopo A., Lopez de la Paz M. (2005) Design of model systems for amyloid formation: lessons for prediction and inhibition. Curr Opin Struct Biol;15:57-63.
16. Rajagopal K., Schneider J.P. (2004) Self-assembling peptides and proteins for nanotechnological applications. Curr Opin Struct Biol;14:480-486.
17. Arnaudov L.N., de Vries R. (2006) Strong impact of ionic strength on the kinetics of fibrilar aggregation of bovine beta-lactoglobulin. Biomacromolecules;7:3490-3498.